Arrow Greentech's Q3 FY26 Performance: Green Growth and Strategic Outlook

Arrow Greentech Limited, a company at the forefront of innovative and sustainable solutions, has unveiled its performance for the third quarter of fiscal year 2026 (Q3 FY26). The company reported a revenue from operations of 56.1 crore rupees, marking a marginal yet positive 1.7% growth compared to Q3 FY25. This quarter's results highlight a strategic shift and strong performance in its burgeoning Green Products segment, signaling a promising trajectory for the future.

The company's profitability metrics also demonstrated resilience. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at 19.2 crore rupees, reflecting a 7.2% year-on-year increase. This was accompanied by a notable EBITDA margin expansion of 175 basis points, reaching 34.3%. Profit After Tax (PAT) for the quarter was 13.3 crore rupees, up 3.6% from the previous year, with PAT margins improving by 19 basis points to 22.8%. These figures underscore Arrow Greentech's commitment to operational efficiency and disciplined financial management.

Segmental Performance: A Tale of Two Engines

The Q3 FY26 results reveal a compelling story across Arrow Greentech's key business segments. The Green Products segment emerged as a significant growth driver, delivering a revenue of 10.3 crore rupees. This represents an impressive 94% year-on-year growth compared to 5.3 crore rupees in Q3 FY25. This segment now contributes 18% to the total revenue, up from 10% in the prior year, solidifying its role as a long-term growth engine built around sustainable materials, water-soluble films, and biodegradable polymer technologies.

Conversely, the High-Tech segment, traditionally the primary revenue contributor, recorded 45.8 crore rupees in revenue. While this segment remained steady in its contribution, it experienced an 8% year-on-year decline. Despite operating in a relatively mature market, the company has maintained revenue momentum through consistent order flow and operational discipline. The steady cash flows generated from the High-Tech segment are crucial for reinvesting into future expansions, thereby balancing stability with future-oriented growth.

Strategic Initiatives and Future Outlook

Arrow Greentech's management, led by Chairman and Managing Director Mr. Shilpan Patel, expressed confidence in the company's performance and future direction. The strategic focus remains on broadening and diversifying the product basket to meet dynamic industry demands. The company's strategy combines financial prudence with innovation-led growth, supported by disciplined capital allocation, strong R&D capabilities, and a diversified revenue base.

In its pharmaceutical arm, Avery Pharmaceuticals, a 100% wholly-owned subsidiary, is redefining oral drug delivery with its patented Embedded Water-Soluble Film Technology, specifically through Mouth Dissolving Strips (MDS). Avery Pharma has over 54 products approved under FSSAI and is actively pursuing product registrations in various international markets, including Russia, Yemen, and Vietnam. The company is also engaged in Contract Development and Manufacturing Organization (CDMO) projects, leveraging its expertise to transform complex oral formulations into scalable, market-ready solutions.

Innovation and Intellectual Property

Arrow Greentech boasts a robust intellectual property portfolio, with 24 granted patents globally across territories including India, UK, USA, Europe, and Sri Lanka. Additionally, it holds 40 in-force registered trademarks. The company's in-house R&D team continuously works on new innovations and patents, focusing on green and high-tech products. This strong IP base covers areas such as security products, brand protection, security papers, water-soluble films, and bio-compostable materials, providing a competitive edge in its niche markets.

Conclusion: A Balanced Approach to Sustainable Growth

Arrow Greentech's Q3 FY26 results reflect a company in transition, successfully nurturing its Green Products segment into a significant growth driver while maintaining stability in its mature High-Tech segment. The management's emphasis on innovation, strategic diversification, and international expansion for its pharmaceutical products positions the company for sustainable growth and long-term value creation. With a strong foundation in intellectual property and a clear strategic roadmap, Arrow Greentech is demonstrating a balanced approach to navigating market dynamics and capitalizing on emerging opportunities.